Kymera Therapeutics, Inc. · NASDAQ:KYMR

Goodman Noah sold 2,500 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 22, 2026

On Jun 22, 2026, Goodman Noah (Chief Business Officer) sold 2,500 Kymera Therapeutics, Inc. shares at US$99.00 for US$248K under a trading plan, leaving 50,195 shares. Filed Jun 22, 2026 (Form 4).

Sold
2,500 shares
Price
US$99.00
Value
US$248K
Holding after
50,195 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockOption exercise2,500US$21.0552,695Direct
Jun 22, 2026Common StockSale2,500US$99.0050,195Direct

Source

View original at SEC

Related